GlassScriptPhysician profile
Amy S Kipp
NPI 1699970855
$1,252.29
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,005 · 2020: $247.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $312.88 | 2019-2020 | |
| Medtronic USA, INC. | $197.71 | 2019 | |
| Collegium Pharmaceutical, INC. | $97.41 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $83.43 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $82.93 | 2019-2020 | |
| Nevro Corp. | $71.60 | 2019-2020 | |
| Lilly USA, LLC | $67.86 | 2019 | |
| Pfizer INC. | $53.80 | 2019 | |
| Si-Bone, INC. | $46.48 | 2019 | |
| Biodelivery Sciences International, INC. | $46.15 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.59 | 2019 | |
| Pacira Therapeutics, INC. | $39.97 | 2019-2020 | |
| Forte Bio-Pharma LLC | $39.93 | 2019-2020 | |
| Boston Scientific Corporation | $22.08 | 2019 | |
| Vertical Pharmaceuticals, LLC | $18.82 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $14.43 | 2019 | |
| Kaleo, INC. | $12.22 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Kipp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.